Patents matching “formulation”

US 9561229

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9562015

Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations

The Regents of the University of Colorado, a body · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9555004

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9554987

Methods and formulations for treating sialic acid deficiencies

Ultragenyx Pharmaceutical Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9549940

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9526760

LEDGF peptides and formulations thereof for treatment of degenerative disorders

The Regents of the University of Colorado, a Body Corporate · Granted Dec 27, 2016 · Expires Dec 22, 2036

US 9511140

Stable VEGF antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

US 9511015

Methods and formulations for treating sialic acid deficiencies

Ultragenyx Pharmaceutical Inc. · Granted Dec 6, 2016 · Expires Dec 1, 2036

US 9474768

Lubricant formulations

Reoxcyn Discoveries Group, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

US 9447401

PH20 polypeptide variants, formulations and uses thereof

HALOZYME, INC. · Granted Sep 20, 2016 · Expires Sep 15, 2036

US 9446075

Compositions derived from stem cell released molecules and methods for formulation thereof

BIOREGENERATIVE SCIENCES, INC. · Granted Sep 20, 2016 · Expires Sep 15, 2036

US 9427469

Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for tissue repair

ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Aug 30, 2016 · Expires Aug 25, 2036

US 9427410

Formulation of acoustically activatable particles having low vaporization energy and methods for using same

Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 30, 2016 · Expires Aug 25, 2036

CA 2977090

FORMULATIONS PHARMACEUTIQUES DE L'INHIBITEUR D'ESTERASE C1

CSL BEHRING GMBH [DE] · Granted Aug 25, 2016 · Expires Aug 20, 2036

US 9420821

Drinking water formulation and method and article relating to same

ESSENTIALIFE HOMEOPATHICS · Granted Aug 23, 2016 · Expires Aug 18, 2036

US 9422413

Elastomer formulations comprising discrete carbon nanotube fibers

MOLECULAR REBAR DESIGN, LLC · Granted Aug 23, 2016 · Expires Aug 18, 2036

US 9415109

Stable non-aggregating nucleic acid lipid particle formulations

Alnylam Pharmaceuticals, Inc. · Granted Aug 16, 2016 · Expires Aug 11, 2036

US 9416167

Stable liquid formulations of dimer VEGF antagonists

REGENERON PHARMACEUTICALS, INC. · Granted Aug 16, 2016 · Expires Aug 11, 2036

US 9409662

Formulations of albu-BChE, preparation and uses thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 9, 2016 · Expires Aug 4, 2036

US 9408845

Formulations containing pyridazine compounds

Northwestern University · Granted Aug 9, 2016 · Expires Aug 4, 2036

US 9402898

Stabilized formulations containing anti-Ang2 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Aug 2, 2016 · Expires Jul 28, 2036

US 9394234

Lipid formulations

ARBUTUS BIOPHARMA CORPORATION · Granted Jul 19, 2016 · Expires Jul 14, 2036

US 9393305

Etanercept formulations stabilized with xylitol

Coherus BioSciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

US 9382256

Formulation of Syk inhibitors

GILEAD CONNECTICUT, INC. · Granted Jul 5, 2016 · Expires Jun 30, 2036